World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
37847
World Ranking
9580
National Ranking
934

Overview

Nigel H. Russell is affiliated with the University of Nottingham in the United Kingdom. Their research primarily focuses on Medicine, with a strong emphasis on Hematology, molecular biology, public health, genetics, and oncology. This diverse range of subfields reflects the complexity and interdisciplinary nature of their work in disease biology and treatment.

The scientist has contributed notably to several topics within hematologic malignancies and treatments. Their main areas of research include:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Retinoids in leukemia and cellular processes

Nigel H. Russell has a significant publication record with frequent publications in the following venues:

  • Blood
  • British Journal of Haematology
  • Blood Advances
  • HemaSphere
  • Journal of Clinical Oncology

Among their recent papers are:

  • "Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia," published in 2022 in the New England Journal of Medicine
  • "Molecular MRD status and outcome after transplantation in NPM1-mutated AML," published in 2020 in Blood
  • "Unified classification and risk-stratification in Acute Myeloid Leukemia," published in 2022 in Nature Communications
  • "The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants," published in 2020 in Nature Communications
  • "Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia," published in 2020 in British Journal of Haematology

Collaboration is an important aspect of their work. Frequent co-authors include:

  • Richard Dillon
  • Amanda Gilkes
  • Mike Dennis
  • Nicola Potter
  • Steven Knapper

This pattern of co-authorship indicates engagement with a network of researchers in similar or complementary fields. Nigel H. Russell's work spans clinical and molecular studies, contributing to understanding and developing treatments for various forms of leukemia and related hematological disorders.

Best Publications

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Assessment of Minimal Residual Disease in Standard-Risk AML.

    Adam Ivey;Robert Kerrin Hills;Michael A. Simpson;Jelena V. Jovanovic

  • Targeting FLT3 mutations in AML: review of current knowledge and evidence.

    Naval Daver;Richard F. Schlenk;Nigel H. Russell;Mark J. Levis

  • Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen

  • Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

    Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison

  • Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)

    Norbert Schmitz;Peter Dreger;Meinolf Suttorp;Ernst B. Rohwedder

  • Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

    Stephen P. Robinson;Anthony H. Goldstone;Stephen Mackinnon;Angelo Carella

  • Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

    Alan K Burnett;Nigel H Russell;Robert Kerrin Hills;David Bowen

  • Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Miguel A. Sanz;Miguel A. Sanz;Pierre Fenaux;Martin S. Tallman;Elihu H. Estey

  • Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

    G. Gahrton;H. Svensson;M. Cavo;J. Apperley

  • The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

    Gareth J. Morgan;Walter M. Gregory;Faith E. Davies;Sue E. Bell

  • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

    Oliver C. Goodyear;Mike Dennis;Nadira Y. Jilani;Nadira Y. Jilani;Justin Loke

  • Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

    Alan Kenneth Burnett;Nigel H. Russell;Robert Kerrin Hills;Jonathan Kell

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

    Jorge E. Cortes;Samer Khaled;Giovanni Martinelli;Alexander E. Perl

  • Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    Alan Kenneth Burnett;Nigel H. Russell;Robert Kerrin Hills;Ann E. Hunter

  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella

  • Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

    Andy C. Rawstron;Ben Kennedy;Ben Kennedy;Ben Kennedy;Paul A. S. Evans;Paul A. S. Evans;Paul A. S. Evans;Faith E. Davies;Faith E. Davies;Faith E. Davies

  • Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

    P. Ljungman;K. N. Ward;B. N. Crooks;A. Parker

Frequent Co-Authors

Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Donald Milligan
Donald Milligan University of Birmingham
Gareth J. Morgan
Gareth J. Morgan Boston University
Graham Jackson
Graham Jackson University of Newcastle Australia
Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Mark T. Drayson
Mark T. Drayson University of Birmingham
Walter M Gregory
Walter M Gregory University of Leeds
David Grimwade
David Grimwade King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine, a wide range of online degrees and certifications can help you build a rewarding healthcare career. For those passionate about pharmaceuticals, pursuing the best online pharmacy school can lead to advanced roles in pharmacy or research, often with flexible online options for working professionals.

Technology is another growing area. Earning a health information technology online degree helps students develop crucial skills in electronic health records, data analysis, and healthcare IT compliance—opening doors to administrative or analyst positions.

Certification programs are also valuable entry points. The cheapest medical coding certification online equips students with foundational knowledge for medical billing and coding roles, which are in high demand across hospitals, clinics, and insurance companies.

Those aiming for clinical leadership can consider the cheapest fnp programs. Family Nurse Practitioners play a vital primary care role, and affordable online pathways make this advanced degree more accessible for nursing professionals.

Best Scientists Citing Nigel H. Russell

Trending Scientists

Recently Published Articles